Virtus ETF Advisers’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31,597
| Closed | -$54.7K | – | 645 |
|
|
2024
Q4 | $54.7K | Buy |
31,597
+9,494
| +43% | +$16.4K | 0.02% | 456 |
|
|
2024
Q3 | $44.4K | Buy |
22,103
+394
| +2% | +$792 | 0.02% | 444 |
|
|
2024
Q2 | $48.6K | Buy |
+21,709
| New | +$48.6K | 0.02% | 444 |
|
|
2022
Q2 | – | Sell |
-10,878
| Closed | -$71K | – | 474 |
|
|
2022
Q1 | $71K | Sell |
10,878
-641
| -6% | -$4.18K | 0.03% | 349 |
|
|
2021
Q4 | $134K | Buy |
11,519
+3,251
| +39% | +$37.8K | 0.05% | 365 |
|
|
2021
Q3 | $154K | Sell |
8,268
-429
| -5% | -$7.99K | 0.07% | 335 |
|
|
2021
Q2 | $184K | Buy |
+8,697
| New | +$184K | 0.08% | 381 |
|